MedPath
HSA Approval

REPLENINE-VF 500 FOR INJECTION

SIN08984P

REPLENINE-VF 500 FOR INJECTION

REPLENINE-VF 500 FOR INJECTION

October 30, 1996

EURO ASIA MEDICO PTE. LTD.

EURO ASIA MEDICO PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEURO ASIA MEDICO PTE. LTD.
Licence HolderEURO ASIA MEDICO PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

B02BD04

coagulation factor IX

Manufacturer Information

EURO ASIA MEDICO PTE. LTD.

Siegfried Hameln GmbH (for WFI)

Bio Products Laboratory

Active Ingredients

COAGULATION FACTOR IX (HUMAN) (FREEZE-DRIED)

min 500 iu/vial

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REPLENINE-VF 500 FOR INJECTION - HSA Approval | MedPath